Maharaj Nicole, Swarath Steven, Seecheran Rajeev, Seecheran Valmiki, Panday Avidesh, Seecheran Naveen
Medicine, North Central Regional Health Authority, Port of Spain, TTO.
Internal Medicine, University of Kansas School of Medicine, Wichita, USA.
Cureus. 2023 Jan 26;15(1):e34236. doi: 10.7759/cureus.34236. eCollection 2023 Jan.
We present a case of a 15-year-old South Asian male who developed suspected postural orthostatic tachycardia syndrome (POTS) two weeks after receiving the Pfizer-BioNTech coronavirus disease 2019 (COVID-19) vaccine booster, which was successfully managed with low-dose fludrocortisone and ivabradine. Clinicians should be aware of the Pfizer-BioNTech COVID-19 vaccine being implicated with the onset of POTS.
我们报告一例15岁的南亚男性病例,该患者在接种辉瑞-生物科技公司的2019冠状病毒病(COVID-19)加强疫苗两周后出现疑似体位性直立性心动过速综合征(POTS),通过低剂量氟氢可的松和伊伐布雷定成功治疗。临床医生应意识到辉瑞-生物科技公司的COVID-19疫苗与POTS的发病有关。